Gland Pharma reports almost two and a half fold jump in Q4 consolidated net profit

23 May 2024 Evaluate

Gland Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported over 4-fold jump in its net profit at Rs 321.41 crore for the quarter under review as compared to Rs 79.21 crore for the same quarter in the previous year. Even, the total income of the company increased by 48.21% at Rs 1221.79 crore for Q4FY24 as compared Rs 824.36 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported almost two and a half fold jump in its net profit at Rs 192.42 crore for fourth quarter ended March 31, 2024 as compared to Rs 78.68 crore for the same quarter in the previous year. Total income of the company increased by 91.71% at Rs 1579.59 crore for Q4FY24 as compared Rs 823.95 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 34.48% rise in its net profit at Rs 1043.33 crore as compared to Rs 775.83 crore for the previous year. Total income of the company increased by 12.37% at Rs 4334.09 crore for year under review as compared to Rs 3856.99 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 1.09% fall in its net profit at Rs 772.46 crore as compared to Rs 781.04 crore for the previous year. Total income of the company increased by 50.97% at Rs 5834.96 crore for year under review as compared to Rs 3865.06 crore for year ended March 31, 2023.


Gland Pharma Share Price

1756.55 -31.95 (-1.79%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.